BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Fatty acid metabolic process
,
Arthritis
,
Prostate
,
DNA fingerprint
,
Valproic acid
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
IL- 25
Summary
General Info
Curated Studies
Most Correlated Studies
Inflammatory response cells from IL-25 treated lungs - expression patterns
Progenitor B BaF3 cells with DOX-induced BCR-ABL expression in the presence or absence of IL-3
1,25-dihydroxyvitamin D3-treated human monocyte-derived dendritic cells
Primary keratinocytes treated with Interleukin-25
Monocytes from healthy donors cultured with IL-10, IL-15, or IL-4
Explore Curated Studies Results
Literature
Most Relevant Literature
IL-25 Impact on Malignant B Cells Survival and T Cells Activation in Chronic Lymphocytic Leukemia.
The expression of interleukin-25 increases in human coronary artery disease and is associated with t…
IL-25 Induced ROS-Mediated M2 Macrophage Polarization via AMPK-Associated Mitophagy.
Allergen-Induced Increases in Interleukin-25 and Interleukin-25 Receptor Expression in Mature Eosino…
Nasal interleukin 25 as a novel biomarker for patients with chronic rhinosinusitis with nasal polyps…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety and Biological Activity of TroVax® Vaccine Given With IL-2 in Renal Cell Carcinoma
Topical IL-1-Ra for Treatment of Posterior Blepharitis
Validation of the French Version of the Stapesplasty Outcome Test 25 (SPOT-25)
Low-dose IL-2 in Established T1D - The "PROREG" Study
HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ